Stay updated on Lumateperone Long-Acting Injectable in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Long-Acting Injectable in Schizophrenia Clinical Trial page.

Latest updates to the Lumateperone Long-Acting Injectable in Schizophrenia Clinical Trial page
- Check6 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the record history. The HHS Vulnerability Disclosure item and the previous revision entry 'Revision: v3.3.2' were removed from the page.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedThe Record History shows a new version entry Revision: v3.3.2 added and the previous Revision: v3.2.0 removed; this is a minor bookkeeping update that does not affect the study's data or conduct. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe government funding notice about potential delays and operating status was removed from the page.SummaryDifference0.8%

- Check56 days agoChange DetectedA new version entry dated 2022-12-01 was added, showing changes to Recruitment Status and other study details (Study Status, Study Design, Outcome Measures, Contacts/Locations).SummaryDifference0.1%

- Check85 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference13%

- Check92 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Lumateperone Long-Acting Injectable in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Long-Acting Injectable in Schizophrenia Clinical Trial page.